FDA to Assess First Drug Meant to Prevent Peanut Allergy
Palforzia is a capsule containing a pharmaceutical-grade dose of the peanut protein.
Palforzia is a capsule containing a pharmaceutical-grade dose of the peanut protein.
The percentage of adults who used cost-saving strategies in the previous 12 months decreased from 2013 through 2015 and remained stable from 2015 through 2017.
Few advertisements discussed the conditions’ biologic nature, risk factors or causes, or prevalence in the population.
Quality and variability of free-text directions in ambulatory e-prescriptions were examined.
Interventions intended to reduce inappropriate antibiotic prescribing may require ongoing reinforcement.
Internal medicine patients are frequently prescribed potentially inappropriate medications, but screening tools can detect clinically relevant potentially inappropriate medications.
Monopoly periods for brand-name prescription drug markets are usually defined by patents and regulatory exclusivity earned at the time of FDA approval.
A recent study examined whether expedited drug approvals have different rates of safety-related label changes compared with drugs approved through standard pathways.
The most effective solution to the opioid crisis may not be abuse-deterrent opioid formulations, according to an editorial published in the New England Journal of Medicine.
While the majority of elderly patients are aware of medication harm, most are unfamiliar with deprescribing.